Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction

Europace

Volumn 14, Issue 7, 2012, Pages 968-974

  Clementy, Nicolas ^a   Pierre, Bertrand ^a   Lallemand, Bndicte ^a   Marie, Olivier ^a   Lemoine, Eric ^a   Cosnay, Pierre ^a   Fauchier, Laurent ^a   Babuty, Dominique ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

High rate cut off; Implantable cardioverter defibrillator; Primary prevention; Programming; Shock; Sudden cardiac death

Indexed keywords

ADULT; AGED; ARTICLE; BIVENTRICULAR ASSIST DEVICE; CONTROL SYSTEM; DEFIBRILLATOR; ELECTRIC SHOCK; FEMALE; FOLLOW UP; HEART BEAT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HEMATOMA; HIGH RATE CUT OFF PROGRAMMING; HUMAN; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NOISE; NONISCHEMIC CARDIOMYOPATHY; OUTCOME ASSESSMENT; PRESYNCOPE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SURGICAL INFECTION; SYNCOPE;

DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84863007630     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus028     Document Type: Article

References (25)

1. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 2008;5:e1-62.
2. Daubert JP, ZarebaW, Cannom DS, McNitt S, Rosero SZ,Wang P et al., MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-65.
3. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
4. Francis J, Johnson B, Niehaus M. Quality of life in patients with implantable cardioverter defibrillators. Indian Pacing Electrophysiol J 2006;6:173-81.
5. Sears SF, Sowell LD, Kuhl EA, Kovacs AH, Serber ER, Handberg E et al. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin Electrophysiol 2007;30: 858-64.
6. Messali A, Thomas O, Chauvin M, Coumel P, Leenhardt A. Death due to an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2004;15:953-6.
7. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden death in patients with implantable cardioverter defibrillators: the importance of postshock electromechanical dissociation. J Am Coll Cardiol 2002;39:1323-8.
8. Gunderson BD, Abeyratne AI, Olson WH, Swerdlow CD. Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverterdefibrillator aborted and unnecessary shocks. Pacing Clin Electrophysiol 2007;30: 157-65.
9. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW et al., PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008;52:541-50.
10. Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J 2009;30: 2758-67.
11. Israel CW. How to avoid inappropriate therapy. Curr Opin Cardiol 2008;23:65-71.
12. Veltmann C, Kuschyk J, Schimpf R, Streitner F, Schoene N, Borggrefe M et al. Prevention of inappropriate ICD shocks in patients with Brugada syndrome. Clin Res Cardiol 2010;99:37-44.
13. Biffi M, Ziacchi M, Bertini M, Sangiorgi D, Corsini D, Martignani C et al. Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 2008;10:1288-95.
14. Mansour F, Khairy P. ICD monitoring zones: intricacies, pitfalls, and programming tips. J Cardiovasc Electrophysiol 2008;19:568-74.
15. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
16. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005;111:2898-905.
17. Mansour F, Khairy P. Programming ICDs in the modern era beyond out-of-the box settings. Pacing Clin Electrophysiol 2011;34:506-20.
18. Duncan E, Thomas G, Johns N, Pfeffer C, Appanna G, Shah N et al. Do traditional VT zones improve outcome in primary prevention ICD patients? Pacing Clin Electrophysiol 2010;33:1353-8.
19. Saeed M, Neason CG, Razavi M, Chandiramani S, Alonso J, Natarajan S et al. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial. J Cardiovasc Electrophysiol 2010;21:1349-54.
20. Chemello D, Subramanian A,Watkins S, Nair K, Nanthakumar K. Implantable cardioverter defibrillator: charge saver, not syncope saver! Can J Cardiol 2010;26: e341-3.
21. GrimmW, Plachta E, Maisch B. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter- defibrillator therapy. Pacing Clin Electrophysiol 2006;29:759-64.
22. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al., Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
23. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation 2006;113:2871-9.
24. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ et al. Inappropriate implantable cardioverter-defibrillators shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011;57:556-62.
25. Gilliam FR, Hayes DL, Boehmer JP, Day J, Heidenreich PA, Seth M et al. Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study. J Cardiovasc Electrophysiol. 2011; 22:1023-9.